In the present study, there was a 10.1% and 9.3% rate of PPOI in the training and validation cohort, respectively. This incidence was different from previous reports. Wolthuis et al. [3,4] found the rate of PPOI was 15.9% after colorectal resection [3] and Vather et al. [14] reported that PPOI occurred in 88 of 327 patients (26.9%) undergoing elective colorectal surgery [[i]]. Liang et al. demonstrated that the overall PPOI rate was 21.5% in 311 patients diagnosed with gastric or colorectal cancer [[ii]]. The difference of incidence was possibly due to ERAS programs have been widely implemented in our study.
Statistically significant differences were found in hypertension between the training and validation cohorts, but hypertension itself was not found to be associated with PPOI. In general, baseline data were essentially balanced in the two cohorts. The AUC of the nomogram was 0.788 in the training. The calibration plots showed a good agreement between nomogram prediction and actual observation, indicating that the model had a good diagnostic performance and an excellent calibration. In addition, the external validation of the nomogram showed a satisfactory outcome, which indicated that our nomogram could be used in various populations and clinical scenarios.
An age older than 65 years was identified as an independent risk factor for PPOI. This may be due to the fact that older individuals generally have more medical comorbidity and clinical frailty, and poorer nutritional and functional status compared with their younger counterparts [[iii]]. Our result emphasizes that postoperative surveillance should be especially carefully achieved in such patients who have an increased risk of morbidity and mortality after colorectal cancer surgery [[iv]].
The fact of male sex has also been shown to affect PPOI following colorectal resection. Consistent with the present study, some studies confirmed that the male sex was associated with increased risk of PPOI in elective colorectal surgery [[v]-[[vi]] [vii]]. This difference is explained by the narrower male pelvis which may make the surgery more difficult and challenging, and potentially secondary to the effects of estrogen and progesterone receptors throughout the gastrointestinal tract and differences in enteric nervous system signaling [17,[viii]].
Minimally invasive approaches include laparoscopic and robotic surgery. The advantages of robotic surgical systems such as superior instrumentatione and field of vision enable precise dissection in confined spaces such as the pelvis, allowing it to have rapidly gained acceptance in colorectal surgery [[ix]]. The robotic surgical systems for the treatment of colorectal cancer were introduced into this hospital in 2020, but only a minority of patients have been treated with robotic surgery because of its high cost. Previous studies have shown that there are no significant differences between laparoscopic and robotic approaches to PPOI and perioperative mortality [[x], [xi]]. Therefore, we combined laparoscopic and robotic surgery into one group in this study. The surgical approach was the strongest predictor of PPOI in our study. There is high-quality evidence supporting the routine use of a minimally invasive approach to patients with colorectal cancer. Compared with open surgery, minimally invasive surgery has shown better outcomes, including less postoperative pain, shorter time to flatus/bowel motion and oral nutrition, improved cosmesis, less intraoperative blood loss, reduced length of stay, improved cosmesis and similar long-term survival [[xii]-]-[[xiii]][xiv]].
Our finding describes an increased risk for PPOI in those who had opioid analgesic treatment. A multimodal, opioid-sparing, pain management plan should be employed throughout the ERAS [[xv]]. Patient controlled analgesia (PCA) of intravenous opioids was used when the pain control was poor. In addition to their intended central effect on pain receptors, opioids have an undesired influence peripherally in the GI tract, including decreased gastric motility and emptying and inhibiting bowel propulsion [[xvi]]. Opioid related dysmotility plays a central role in postoperative gut dysfunction [[xvii]]. More recently, peripheral μ-opioid receptor antagonists in patients have been developed for treatment or prevention of PPOI after surgery [[xviii]].
Previous studies believed that adherence to judicious intra-operative fluid management protocols was protective against development of PPOI [[xix],[xx]]. Similarly, this study showed that perioperative fluid overload was significantly associated with PPOI. This may be because hypervolemic management may result in electrolyte disturbances and splanchnic edema and increased abdominal pressure with decreased mesenteric blood flow, which in turn elicits disruptive tissue oxygenation and ultimately leads to prolongation of the recovery of bowel function [16].